Procleix Babesia Assay (FDA Approved and CE Marked)
Single-tube, highly sensitive detection of the ribosomal RNA of the Babesia parasite in whole blood specimens.
The Procleix Babesia assay is CE marked and FDA approved.
Assay Characteristics
Assay chemistry
- Procleix Panther system
-
Qualitative, transcription-mediated amplification (TMA)
Indication
- Procleix Panther system
-
Whole blood and blood component screening
Collection tube
- Procleix Panther system
-
Whole blood from K2EDTA, K3EDTA, Sodium Citrate, and Citrate Phosphate Dextrose Adenine Solution
(CPDA) anti-coagulated samples
Pool sizes
- Procleix Panther system
-
ID-NAT, 8, 16
ID-NAT, 8, 16
- Procleix Panther system
-
ID-NAT, 8, 16
Detected pathogen
- Procleix Panther system
-
Babesia parasite (species B. microti, B. divergens, B. duncani, and B. venatorum)
| Platform | Procleix Panther system |
|---|---|
|
Assay chemistry |
Qualitative, transcription-mediated amplification (TMA) |
|
Indication |
Whole blood and blood component screening |
|
Collection tube |
Whole blood from K2EDTA, K3EDTA, Sodium Citrate, and Citrate Phosphate Dextrose Adenine Solution |
|
Pool sizes |
ID-NAT, 8, 16 |
|
ID-NAT, 8, 16 |
ID-NAT, 8, 16 |
|
Detected pathogen |
Babesia parasite (species B. microti, B. divergens, B. duncani, and B. venatorum) |
Explore other Procleix Assays
Expand your blood screening with a comprehensive NAT assay portfolio.